What Is Resveratrol? Benefits, Foods & How It Works

Resveratrol is one of the most studied plant polyphenols in the longevity conversation, largely because of its links to sirtuins, AMPK and mitochondrial biology. This guide explains what it actually is, how it works in the body, where it comes from in the diet, what the evidence does and does not support, and how it compares to another mitochondrial compound: urolithin A.

What resveratrol is

Resveratrol is a naturally occurring polyphenol that belongs to a chemical family called stilbenes. Plants produce it as a defensive compound, a phytoalexin, in response to stress such as fungal infection, ultraviolet light or injury. In supplements and in most research it appears as trans-resveratrol, the more stable and biologically active isomer, as opposed to the cis form.

Public interest in resveratrol grew out of the so-called French paradox, the observation that some populations with diets relatively high in saturated fat but also in red wine appeared to have lower-than-expected rates of cardiovascular problems. Red wine contains resveratrol, and that association drove decades of laboratory work. It is worth being clear up front: an epidemiological association is a starting point for research, not proof that a single molecule is responsible for an outcome.

Dietary sources of resveratrol

You already consume small amounts of resveratrol if you eat a varied plant-forward diet. The best-known food sources include:

• Grapes, especially the skins of red and purple grapes, which is why red wine contains more than white.
• Red wine, though the amounts are modest and vary widely by grape, region and production method.
• Peanuts and peanut products, plus some tree nuts.
• Berries such as blueberries, bilberries and cranberries.
• Dark chocolate and cocoa in smaller quantities.

Most concentrated supplements do not come from grapes at all. The dominant commercial source is Japanese knotweed (Polygonum cuspidatum, also called Fallopia japonica), a plant whose roots are unusually rich in trans-resveratrol and can be standardized to a high percentage.

How resveratrol works in the body

Resveratrol is best understood as a signaling molecule rather than a simple antioxidant, although it does have direct free-radical-scavenging chemistry. Three mechanisms come up repeatedly in the laboratory literature.

Sirtuins (SIRT1)

Much of the original excitement centered on SIRT1, an enzyme in the sirtuin family that depends on NAD+ and is involved in how cells respond to energy availability and stress. Early cell studies suggested resveratrol could activate SIRT1, which in turn influences pathways tied to metabolism and cellular housekeeping. The picture turned out to be more complicated than the first reports implied, and researchers have debated how much of resveratrol's effect is direct versus indirect.

AMPK and mitochondrial biogenesis

A frequently cited mechanistic paper in Cell Metabolism (Price et al., 2012, preclinical) argued that resveratrol's benefits on mitochondrial function in mice depend on AMPK, a central cellular energy sensor, and that SIRT1 is required for that activation. Downstream, this signaling can influence PGC-1 alpha, a master regulator that helps cells build new mitochondria, a process called mitochondrial biogenesis. In plain terms, some of resveratrol's laboratory effects look like the cell being nudged toward the state it reaches during exercise or calorie restriction.

Antioxidant and cell-signaling activity

Resveratrol also interacts with inflammatory and oxidative signaling pathways in cell and animal models. Because these findings are overwhelmingly preclinical, they describe biological plausibility, not confirmed outcomes in people.

What the human evidence supports (and its limits)

Resveratrol has been tested in humans for cardiovascular markers, blood sugar handling, cognition and more. Results across these trials have been genuinely mixed. Some studies report modest changes in specific biomarkers; others find little. Two honest caveats explain much of the inconsistency.

First, bioavailability is a real problem. Resveratrol is absorbed but then very rapidly metabolized in the gut and liver into sulfate and glucuronide conjugates, so blood levels of the free molecule stay low and short-lived. This gap between impressive petri-dish concentrations and what actually circulates in a person is central to why translation has been difficult.

Second, doses, formulations and study populations vary enormously, which makes trials hard to compare. Commonly studied intakes range from around 150 mg to 1,000 mg per day. Because the research is unsettled, resveratrol is best framed as a compound that supports normal metabolic and cellular function as part of a healthy lifestyle, not as something that treats any condition.

Note: topics like heart health, blood sugar and brain function are medical territory. Resveratrol is not a treatment for any disease. If you are managing a health condition, talk to your doctor before adding it.

Resveratrol, mitophagy and how it relates to urolithin A

Both resveratrol and urolithin A show up in longevity discussions because both connect to mitochondria, the structures that generate most of your cellular energy. But they act on different sides of the same coin, which is why people often research them together.

Resveratrol is associated in preclinical work with mitochondrial biogenesis, the building of new mitochondria via the AMPK and PGC-1 alpha pathways described above. Urolithin A is a gut postbiotic your microbiome makes from ellagitannins in pomegranate, walnuts and berries, and it is studied for supporting mitophagy, the cell's process for recycling worn-out mitochondria so healthier ones remain. One angle emphasizes making new; the other emphasizes clearing old.

Importantly, the human evidence base differs. A foundational preclinical paper (Ryu et al., 2016, Nature Medicine) established urolithin A's mitophagy and muscle-function effects in worms and rodents, and human trials followed. Andreux et al. 2019 (Nature Metabolism) was a first-in-human study showing urolithin A was safe and well tolerated up to 1,000 mg per day and produced a mitochondrial gene-expression signature. Later randomized human trials, including Liu and D'Amico et al. 2022 (JAMA Network Open) in older adults and Singh et al. 2022 (Cell Reports Medicine) in middle-aged adults, reported measures related to muscle endurance and strength. A 2024 systematic review in Ageing Research Reviews is appropriately cautious, describing the human evidence as still emerging, with short trials and modest sample sizes. We hold both compounds to the same evidence-first standard.

If you want a side-by-side breakdown, see urolithin A vs resveratrol, and for the deeper picture on mitochondrial recycling read what is mitophagy and our overview of mitochondrial health.

Safety and practical guidance

Resveratrol is generally considered well tolerated at commonly used supplement doses. At higher intakes some people report gastrointestinal effects such as nausea, loose stools or abdominal discomfort. Because resveratrol can influence platelet activity and is processed by liver enzymes that also handle many medications, it may interact with blood thinners and certain drugs. It is not recommended during pregnancy or breastfeeding without medical guidance.

Practical points if you choose to try it: look for products standardized to trans-resveratrol, favor third-party-tested brands, take it with a meal, and start at the lower end. None of this substitutes for a conversation with your own clinician, particularly if you take prescription medication.

To go deeper on the mitochondrial compound we formulate around, start with our urolithin A guide, compare formats in best urolithin A gummies, and see the underlying data in urolithin A clinical studies.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.